Syn-Tech Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 16, 2021 at 03:22 pm EDT
Share
SYN-TECH Chem. & Pharm. Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 983.788 million compared to TWD 946.410 million a year ago. Operating income was TWD 262.372 million compared to TWD 200.610 million a year ago. Net income was TWD 186.742 million compared to TWD 159.473 million a year ago. Basic earnings per share was TWD 6.21 compared to TWD 5.31 a year ago. Diluted earnings per share was TWD 6.2 compared to TWD 5.3 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Company's main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.